The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
African region
COVID-19
pandemic response
public health and social measures
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
04 11 2021
04 11 2021
Historique:
pubmed:
5
11
2021
medline:
8
1
2022
entrez:
4
11
2021
Statut:
epublish
Résumé
The World Health Organization African region recorded its first laboratory-confirmed coronavirus disease-2019 (COVID-19) cases on 25 February 2020. Two months later, all the 47 countries of the region were affected. The first anniversary of the pandemic occurred in a changed context with the emergence of new variants of concern (VOC) and growing COVID-19 fatigue. This study describes the epidemiological trajectory of COVID-19 in the region, summarises public health and social measures (PHSM) implemented and discusses their impact on the pandemic trajectory. As of 24 February 2021, the African region accounted for 2.5% of cases and 2.9% of deaths reported globally. Of the 13 countries that submitted detailed line listing of cases, the proportion of cases with at least one co-morbid condition was estimated at 3.3% of all cases. Hypertension, diabetes and human immunodeficiency virus (HIV) infection were the most common comorbid conditions, accounting for 11.1%, 7.1% and 5.0% of cases with comorbidities, respectively. Overall, the case fatality ratio (CFR) in patients with comorbid conditions was higher than in patients without comorbid conditions: 5.5% vs. 1.0% (P < 0.0001). Countries started to implement lockdown measures in early March 2020. This contributed to slow the spread of the pandemic at the early stage while the gradual ease of lockdowns from 20 April 2020 resulted in an upsurge. The second wave of the pandemic, which started in November 2020, coincided with the emergence of the new variants of concern. Only 0.08% of the population from six countries received at least one dose of the COVID-19 vaccine. It is critical to not only learn from the past 12 months to improve the effectiveness of the current response but also to start preparing the health systems for subsequent waves of the current pandemic and future pandemics.
Identifiants
pubmed: 34732270
doi: 10.1017/S0950268821002429
pii: S0950268821002429
pmc: PMC8712926
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e263Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Références
Cas Lek Cesk. 1968 Aug 9;107(32):975-7
pubmed: 5679073
Science. 2021 Jan 1;371(6524):27-28
pubmed: 33384364
Lancet Microbe. 2020 May;1(1):e12
pubmed: 32835324
Lancet Glob Health. 2021 Jun;9(6):e773-e781
pubmed: 33711262
Int J Infect Dis. 2021 Jan;102:483-488
pubmed: 33010461
Lancet. 2021 Jan 30;397(10272):373
pubmed: 33484634
Lancet. 2021 Apr 3;397(10281):1265-1275
pubmed: 33773118
Pan Afr Med J. 2020 Nov 16;37(Suppl 1):37
pubmed: 33456661
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Afr J Lab Med. 2020 May 14;9(1):1244
pubmed: 32537428
BMJ. 2021 Feb 17;372:n334
pubmed: 33597166
J Glob Health. 2020 Dec;10(2):020348
pubmed: 33110546
Lancet Glob Health. 2021 Jun;9(6):e724-e725
pubmed: 33711261
Lancet. 2021 May 22;397(10288):1885-1894
pubmed: 34022988
Public Health Pract (Oxf). 2020 Nov;1:100038
pubmed: 34173573
New Microbes New Infect. 2018 Sep 21;26:S10-S18
pubmed: 30402238
Biosecur Bioterror. 2013 Sep;11(3):163-9
pubmed: 24041192
Am J Trop Med Hyg. 2021 Mar 8;:
pubmed: 33684067
Health Secur. 2016 May-Jun;14(3):185-8
pubmed: 27314658
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820